AstraZeneca safe drug prices in the United States. Read more. The company will also present results from four cancer studies at ESMO. Read more.
Biohit announces that B shares have been subscribed for with warrants in 2021C and 2022C. Read more.
BioInvent and Transgene. presents translational data and updated clinical results for the oncolytic virus BT-001 at ESMO 2025. Read more.
Episurf announces that a board member has requested to resign from the board. Read more.
Hansa Biopharma reports that data from the GNT-018-IDES study show that imlifidase can be used as pretreatment for gene therapy for patients with Crigler-Najjar syndrome who have antibodies to AAV. Read more.
Intellego Technologies The board responds to speculation and incorrect information in the media and social platforms. Read more.
lundbeck has received Breakthrough Therapy Designation in China for bexicaserin for the treatment of seizures in severe rare epilepsies. Read more.
Monivent has been granted a patent in the US for its technology. Read more.
NanoEcho receives support from Vinnova to develop an application for the EIC Accelerator. Read more.
Nexstim launches NBS 6 for diagnostic use in the US. Read more.
Observe Medical reports preliminary results from the subsequent issue. Read more.
ViroGates announces the receipt of a public tender offer from suPAR Remedy LLC. Read more.
Insider trading & whistleblowing
Herantis Pharma Nykode Therapeutics
Invitations & presentations
Communiqués
Summons
Nomination committees
Change in number of shares and votes
The latest from BioStock
» Corline strengthens position after billion-dollar deal – cash replenished ahead of US launch
» How European companies can succeed in the Chinese deal market
» Big pharma ditches the UK – A stark warning
» Screening - a potential game changer for type 1 diabetes
» SynAct Pharma's CBO: “We are pioneering the future of inflammation care”
» FDA concerns delay Xspray Pharma's Dasynoc approval again